Extracorporeal photoimmunochemotherapy
R Knobler, P Heald - Dermatological phototherapy and photodiagnostic …, 2001 - Springer
Extracorporeal photoimmunochemotherapy (ECP, photopheresis) was introduced in 1987
for the palliative management of cutaneous T-cell lymphoma (CTCL)[1]. ECP was shown to …
for the palliative management of cutaneous T-cell lymphoma (CTCL)[1]. ECP was shown to …
A simplified extracorporeal photopheresis procedure based on single high‐dose ultraviolet A light irradiation shows similar in vitro efficacy
V Buchele, H Hackstein - Transfusion, 2021 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) is one of the most widely used and
effective cell‐based therapies for the treatment of T‐cell–mediated diseases. The patients' …
effective cell‐based therapies for the treatment of T‐cell–mediated diseases. The patients' …
Current clinical applications of extracorporeal photochemotherapy
M Capuano, L Sommese, O Pignalosa… - Therapeutic …, 2015 - Wiley Online Library
From the 1980s, extracorporeal photochemotherapy (ECP) has been shown to be effective
in a variety of pathological conditions such as erythrodermic cutaneous T‐cell lymphoma …
in a variety of pathological conditions such as erythrodermic cutaneous T‐cell lymphoma …
Extracorporeal photopheresis: what is it and when should it be used?
J Scarisbrick - Clinical and experimental dermatology, 2009 - academic.oup.com
Extracorporeal photopheresis (ECP) is a technique that was developed> 20 years ago to
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …
Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8‐methoxypsoralen concentration and by replacing plasma with saline
V Hähnel, AM Brosig, M Ehrenschwender… - …, 2021 - Wiley Online Library
Background Extracorporeal photopheresis (ECP), an apheresis‐based therapy for various
immunological diseases, works mainly by inducing apoptosis in lymphocytes. Several …
immunological diseases, works mainly by inducing apoptosis in lymphocytes. Several …
Extracorporeal photopheresis: lighting the way to immunomodulation
AM Babic - American journal of hematology, 2008 - Wiley Online Library
Photopheresis, initially established as an effective treatment of cutaneous T‐cell lymphoma,
has in recent years also been used to treat chronic graft vs. host disease, heart transplant …
has in recent years also been used to treat chronic graft vs. host disease, heart transplant …
Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art
M Martino, R Fedele, G Cornelio… - Expert Opinion on …, 2012 - Taylor & Francis
Introduction: Extracorporeal photopheresis (ECP) has been extensively used for the
treatment of immune-mediated diseases for over 20 years and has a consistent and …
treatment of immune-mediated diseases for over 20 years and has a consistent and …
Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay
K Chieregato, A Alghisi, C Borghero, F Elice… - … and Apheresis Science, 2015 - Elsevier
Extracorporeal photopheresis (ECP) is accepted as a second-line therapy for the treatment
of acute and chronic steroid-refractory graft versus host disease (GvHD), cutaneous T-cell …
of acute and chronic steroid-refractory graft versus host disease (GvHD), cutaneous T-cell …
Applications of extracorporeal photochemotherapy in “non-oncological” diseases
R Dall'Amico, F Zulian, G Montini… - … Journal of Artificial …, 1993 - journals.sagepub.com
Photopheresis (ECP) is a new therapy for oncological and autoimmune diseases consisting
in the reinfusion of 3-9x 109 leukocytes, taken from the patient by leukapheresis, and treated …
in the reinfusion of 3-9x 109 leukocytes, taken from the patient by leukapheresis, and treated …